TH17 cells in development: An updated view of their molecular identity and genetic programming

Nature Reviews Immunology

Volumn 8, Issue 5, 2008, Pages 337-348

  Dong, Chen ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERFERON REGULATORY FACTOR 4; INTERLEUKIN 12; INTERLEUKIN 17; INTERLEUKIN 21; INTERLEUKIN 22; INTERLEUKIN 6; STAT3 PROTEIN; T LYMPHOCYTE RECEPTOR; TRANSFORMING GROWTH FACTOR BETA; TRANSCRIPTION FACTOR;

ASTHMA; AUTOIMMUNE DISEASE; CD4+ T LYMPHOCYTE; CELL DIFFERENTIATION; COLITIS; EPIGENETICS; GENE EXPRESSION; GENE MUTATION; GENE SEQUENCE; GENETIC TRANSCRIPTION; GENOME; HELPER CELL; HELPER CELL TYPE 17; HEPATITIS; HUMAN; IMMUNE SYSTEM; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; ANIMAL; CELL LINEAGE; COMMUNICABLE DISEASE; CYTOLOGY; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; METABOLISM; PHYSIOLOGY;

ANIMALS; AUTOIMMUNE DISEASES; CELL DIFFERENTIATION; CELL LINEAGE; COMMUNICABLE DISEASES; CYTOKINES; GENE EXPRESSION; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION; INTERLEUKIN-17; T-LYMPHOCYTES, HELPER-INDUCER; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 42649115767     PISSN: 14741733     EISSN: None     Source Type: Journal    
DOI: 10.1038/nri2295     Document Type: Review

References (118)

1. H2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7, 145-173 (1989).
2. H2 cells. Curr. Opin. Hematol. 8, 47-51 (2001).
3. Glimcher, L. H. & Murphy, K. M. Lineage commitment in the immune system: the T helper lymphocyte grows up. Genes Dev. 14, 1693-1711 (2000).
4. Faria, A. M. & Weiner, H. L. Oral tolerance and TGF-β-producing cells. Inflamm. Allergy Drug Targets 5, 179-190 (2006).
5. Grazia Roncarolo, M. et al. Interleukin-10-secreting type 1 regulatory T cells in rodents and humans. Immunol. Rev. 212, 28-50 (2006).
6. Wing, K., Fehervari, Z. & Sakaguchi, S. Emerging possibilities in the development and function of regulatory T cells. Int. Immunol. 18, 991-1000 (2006).
7. Vinuesa, C. G., Tangye, S. G., Moser, B. & Mackay, C. R. Follicular B helper T cells in antibody responses and autoimmunity. Nature Rev. Immunol. 5, 853-865 (2005).
8. Dong, C. Diversification of T-helper-cell lineages: finding the family root of IL-17-producing cells. Nature Rev. Immunol. 6, 329-334 (2006).
9. H17 lineage. Curr. Opin. Immunol. 18, 349-356 (2006).
10. H cells. J. Immunol. 165, 6107-6115 (2000).
11. Dong, C. & Nurieva, R. I. Regulation of immune and autoimmune responses by ICOS. J. Autoimmun. 21, 255-260 (2003).
12. Murphy, C. A. et al. Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation. J. Exp. Med. 198, 1951-1957 (2003).
13. Langrish, C. L. et al. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J. Exp. Med. 201, 233-240 (2005).
14. + effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nature Immunol. 6, 1123-1132 (2005).
15. Park, H. et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin-17. Nature Immunol. 6, 1133-1141 (2005).
16. Kolls, J. K. & Linden, A. Interleukin-17 family members and inflammation. Immunity 21, 467-476 (2004).
17. Moseley, T. A., Haudenschild, D. R., Rose, L. & Reddi, A. H. Interleukin-17 family and IL-17 receptors. Cytokine Growth Factor Rev. 14, 155-174 (2003).
18. H17 cells and their possible regulation by cytokines.
19. H-17 cells in the circle of immunity and autoimmunity. Nature Immunol. 8, 345-350 (2007).
20. H2 hypothesis of T cell-mediated tissue damage. Nature Med. 13, 139-145 (2007).
21. H17 cells and drives IL-17 production in a STAT3-dependent manner. J. Biol. Chem. 282, 34605-34610 (2007).
22. Yao, Z. et al. Herpesvirus saimiri encodes a new cytokine, IL-17, which binds to a novel cytokine receptor. Immunity 3, 811-821 (1995).
23. Toy, D. et al. Cutting edge: Interleukin-17 signals through a heteromeric receptor complex. J. Immunol. 177, 36-39 (2006).
24. Shalom-Barak, T., Quach, J. & Lotz, M. Interleukin-17-induced gene expression in articular chondrocytes is associated with activation of mitogen-activated protein kinases and NF-κB. J. Biol. Chem. 273, 27467-27473 (1998).
25. Schwandner, R., Yamaguchi, K. & Cao, Z. Requirement of tumor necrosis factor receptor-associated factor (TRAF)6 in interleukin-17 signal transduction. J. Exp. Med. 191, 1233-1240 (2000).
26. Chang, S. H., Park, H. & Dong, C. Act1 adaptor protein is an immediate and essential signaling component of interleukin-17 receptor. J. Biol. Chem. 281, 35603-35607 (2006).
27. Qian, Y. et al. The adaptor Act1 is required for interleukin-17-dependent signaling associated with autoimmune and inflammatory disease. Nature Immunol. 8, 247-256 (2007).
28. Ogawa, A., Andoh, A., Araki, Y., Bamba, T. & Fujiyama, Y. Neutralization of interleukin-17 aggravates dextran sulfate sodium-induced colitis in mice. Clin. Immunol. 110, 55-62 (2004).
29. Ruddy, M. J. et al. Functional cooperation between interleukin-17 and tumor necrosis factor-α is mediated by CCAAT/enhancer-binding protein family members. J. Biol. Chem. 279, 2559-2567 (2004).
30. Ye, P. et al. Requirement of interleukin-17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense. J. Exp. Med. 194, 519-527 (2001).
31. Nakae, S., Nambu, A., Sudo, K. & Iwakura, Y. Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice. J. Immunol. 171, 6173-6177 (2003).
32. Bush, K. A., Farmer, K. M., Walker, J. S. & Kirkham, B. W. Reduction of joint inflammation and bone erosion in rat adjuvant arthritis by treatment with interleukin-17 receptor IgG1 Fc fusion protein. Arthritis Rheum. 46, 802-805 (2002).
33. Komiyama, Y. et al. IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis. J. Immunol. 177, 566-573 (2006).
34. Hsu, H.-C. et al. Interleukin-17-producing T helper cells and interleukin-17 orchestrate autoreactive germinal center development in autoimmune BXD2 mice. Nature Immunol. 9, 166-175 (2008).
35. Nakae, S. et al. Antigen-specific T cell sensitization is impaired in IL-17-deficient mice, causing suppression of allergic cellular and humoral responses. Immunity 17, 375-387 (2002).
36. Schnyder-Candrian, S. et al. Interleukin-17 is a negative regulator of established allergic asthma. J. Exp. Med. 203, 2715-2725 (2006).
37. Happel, K. I. et al. Cutting edge: Roles of Toll-like receptor 4 and IL-23 in IL-17 expression in response to Klebsiella pneumoniae infection. J. Immunol. 170, 4432-4436 (2003).
38. + T lymphocytes and its regulation by protein kinase A pathway. Cytokine 11, 257-266 (1999).
39. - iNKT cell population involved in airway neutrophilia. J. Exp. Med. 204, 995-1001 (2007).
40. + T cell responses after vaccination and during Mycobacterium tuberculosis challenge. Nature Immunol. 8, 369-377 (2007).
41. + γδ T cells control early infiltration of neutrophils after Escherichia coli infection via IL-17 production. J. Immunol. 178, 4466-4472 (2007).
42. H17-cell differentiation in mice is initiated by TGFβ and IL-6.
43. Hizawa, N., Kawaguchi, M., Huang, S. K. & Nishimura, M. Role of interleukin-17F in chronic inflammatory and allergic lung disease. Clin. Exp. Allergy 36, 1109-1114 (2006).
44. Chang, S. H. & Dong, C. A novel heterodimeric cytokine consisting of IL-17 and IL-17F regulates inflammatory responses. Cell Res. 17, 435-440 (2007).
45. + T cells. J. Biol. Chem. 282, 13447-13455 (2007).
46. H2 responses in the lung: in vivo function of the novel cytokine IL-25. J. Immunol. 169, 443-453 (2002).
47. Oda, N. et al. Interleukin-17F induces pulmonary neutrophilia and amplifies antigen-induced allergic response. Am. J. Respir. Crit. Care Med. 171, 12-18 (2005).
48. Kawaguchi, M. et al. Identification of a novel cytokine, ML-1, and its expression in subjects with asthma. J. Immunol. 167, 4430-4435 (2001).
49. Hymowitz, S. G. et al. IL-17s adopt a cystine knot fold: structure and activity of a novel cytokine, IL-17F, and implications for receptor binding. Embo J. 20, 5332-5341 (2001).
50. Kuestner, R. E. et al. Identification of the IL-17 receptor related molecule IL-17RC as the receptor for IL-17F. J. Immunol. 179, 5462-5473 (2007).
51. + T lymphocytes. Cell Res. 16, 902-907 (2006).
52. H17 cells and cooperatively enhance expression of antimicrobial peptides. J. Exp. Med. 203, 2271-2279 (2006).
53. H17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis. Nature 445, 648-651 (2007).
54. Wolk, K. et al. IL-22 increases the innate immunity of tissues. Immunity 21, 241-254 (2004).
55. Aujla, S. J. et al. IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia. Nature Med. 14, 275-281 (2008).
56. Zheng, Y. et al. Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens. Nature Med. 14, 282-289 (2008).
57. H17 cells in an IL-23-dependent fashion, but not required for the development of autoimmune encephalomyelitis. J. Immunol. 179, 8098-8104 (2007).
58. Zenewicz, L. A. et al. Interleukin-22 but not interleukin-17 provides protection to hepatocytes during acute liver inflammation. Immunity 27, 647-659 (2007).
59. Wilson, N. J. et al. Development, cytokine profile and function of human interleukin-17-producing helper T cells. Nature Immunol. 8, 950-957 (2007).
60. H17 cells. Nature 448, 484-487 (2007).
61. Nurieva, R. et al. Essential autocrine regulation by IL-21 in the generation of inflammatory T cells. Nature 448, 480-483 (2007).
62. H17-cell differentiation.
63. H2 effector cells that provide help for B cells. J. Immunol. 173, 68-78 (2004).
64. Williams, I. R. CCR6 and CCL20: partners in intestinal immunity and lymphorganogenesis. Ann. NY Acad. Sci. 1072, 52-61 (2006).
65. H17 cells to inflamed joints via CCL20 in rheumatoid arthritis and its animal model. J. Exp. Med. 204, 2803-2812 (2007).
66. H17 cells. J. Exp. Med. 204, 1849-1861 (2007).
67. Nurieva, R. et al. T-cell tolerance or function is determined by combinatorial costimulatory signals. EMBO J. 25, 2623-2633 (2006).
68. H17 and regulatory T cells. Nature 441, 235-238 (2006).
69. H17 lineage. Nature 441, 231-234 (2006).
70. + regulatory T cells via a TGF-β and retinoic acid dependent mechanism. J. Exp. Med. 204, 1757-1764 (2007).
71. H17 polarization and enhances FoxP3 expression through a Stat-3/Stat-5 independent signaling pathway. Blood 111, 1013-1020 (2008).
72. + regulatory T cells. J. Immunol. 179, 3724-3733 (2007).
73. H17 and regulatory T cell differentiation mediated by retinoic acid. Science 317, 256-260 (2007).
74. Schambach, F., Schupp, M., Lazar, M. A. & Reiner, S. L. Activation of retinoic acid receptor-α favours regulatory T cell induction at the expense of IL-17-secreting T helper cell differentiation. Eur. J. Immunol. 37, 2396-2399 (2007).
75. H17-cell differentiation.
76. H17-cell differentiation.
77. H17 cells.
78. H17-cell differentiation. Immunity 26, 579-591 (2007).
79. Akimzhanov, A. M., Yang, X. O. & Dong, C. Chromatin remodeling of interleukin-17 (IL-17)-IL-17F cytokine gene locus during inflammatory helper T cell differentiation. J. Biol. Chem. 282, 5969-5972 (2007).
80. Acosta-Rodriguez, E. V., Napolitani, G., Lanzavecchia, A. & Sallusto, F. Interleukins 1β and 6 but not transforming growth factor-β are essential for the differentiation of interleukin-17-producing human T helper cells. Nature Immunol. 8, 942-949 (2007).
81. Harada, M. et al. IL-21-induced Bε cell apoptosis mediated by natural killer T cells suppresses IgE responses. J. Exp. Med. 203, 2929-2937 (2006).
82. Hunter, C. A. New IL-12-family members: IL-23 and IL-27, cytokines with divergent functions. Nature Rev. Immunol. 5, 521-531 (2005).
83. Cua, D. J. et al. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 421, 744-748 (2003).
84. Aggarwal, S., Ghilardi, N., Xie, M. H., De Sauvage, F. J. & Gurney, A. L. Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17. J. Biol. Chem. 278, 1910-1914 (2003).
85. H1 responses. J. Immunol. 176, 4616-4621 (2006).
86. Thakker, P. et al. IL-23 is critical in the induction but not in the effector phase of experimental autoimmune encephalomyelitis. J. Immunol. 178, 2589-2598 (2007).
87. H17 cell-mediated pathology. Nature Immunol. 8, 1390-1397 (2007).
88. Duerr, R. H. et al. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 314, 1461-1463 (2006).
89. Wellcome Trust Case Control Consortium. Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants. Nature Genet. 39, 1329-1337 (2007).
90. Uhlig, H. H. et al. Differential activity of IL-12 and IL-23 in mucosal and systemic innate immune pathology. Immunity 25, 309-318 (2006).
91. Okamoto, H. & Momohara, S. Interleukin-12/23 monoclonal antibody for psoriasis. N. Engl. J. Med. 356, 2003 (2007).
92. Langowski, J. L. et al. IL-23 promotes tumour incidence and growth. Nature 442, 461-465 (2006).
93. Schiffenbauer, J. et al. The induction of EAE is only partially dependent on TNF receptor signaling but requires the IL-1 type I receptor. Clin. Immunol. 95, 117-123 (2000).
94. Sutton, C., Brereton, C., Keogh, B., Mills, K. H. & Lavelle, E. C. A crucial role for interleukin (IL)-1 in the induction of IL-17-producing T cells that mediate autoimmune encephalomyelitis. J. Exp. Med. 203, 1685-1691 (2006).
95. Laurence, A. et al. Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation. Immunity 26, 371-381 (2007).
96. Batten, M. et al. Interleukin-27 limits autoimmune encephalomyelitis by suppressing the development of interleukin-17-producing T cells. Nature Immunol. 7, 929-936 (2006).
97. Stumhofer, J. S. et al. Interleukin-27 negatively regulates the development of interleukin-17-producing T helper cells during chronic inflammation of the central nervous system. Nature Immunol. 7, 937-945 (2006).
98. H17 function in autoimmune inflammation. J. Exp. Med. 204, 161-170 (2007).
99. Angkasekwinai, P. et al. Interleukin-25 promotes the initiation of proallergic type 2 responses. J. Exp. Med. 204, 1509-1517 (2007).
100. + T cells. Nature Immunol. 3, 549-557 (2002).
101. H1 cells. Immunity 11, 677-688 (1999).
102. H cells. J. Immunol. 178, 4901-4907 (2007).
103. Chen, Z. et al. Selective regulatory function of Socs3 in the formation of IL-17-secreting T cells. Proc. Natl Acad. Sci. USA 103, 8137-8142 (2006).
104. Reg in the steady state. Int. Immunol. 19, 695-702 (2007).
105. Kimura, A., Naka, T. & Kishimoto, T. IL-6-dependent and -independent pathways in the development of interleukin-17-producing T helper cells. Proc. Natl Acad. Sci. USA 104, 12099-12104 (2007).
106. H17-cell development.
107. H17-dependent autoimmunity. J. Immunol. 179, 4313-4317 (2007).
108. Jetten, A. M. Recent advances in the mechanisms of action and physiological functions of the retinoid-related orphan receptors (RORs). Curr. Drug Targets Inflamm. Allergy 3, 395-412 (2004).
109. Eberl, G. & Littman, D. R. The role of the nuclear hormone receptor RORγt in the development of lymph nodes and Peyer's patches. Immunol. Rev. 195, 81-90 (2003).
110. H-17 cells requires interferon-regulatory factor 4. Nature Immunol. 8, 958-966 (2007).
111. Hu, C.-M., Jang, S. Y., Fanzo, J. C. & Pernis, A. B. Modulation of T cell cytokine production by interferon regulatory factor-4. J. Biol. Chem. 277, 49238-49246 (2002).
112. Lohoff, M. et al. Dysregulated T helper cell differentiation in the absence of interferon regulatory factor 4. Proc. Natl Acad. Sci. USA 99, 11808-11812 (2002).
113. Rengarajan, J. et al. Interferon regulatory factor 4 (IRF4) interacts with NFATc2 to modulate interleukin 4 gene expression. J. Exp. Med. 195, 1003-1012 (2002).
114. Lee, G. R., Kim, S. T., Spilianakis, C. G., Fields, P. E. & Flavell, R. A. T helper cell differentiation: regulation by cis elements and epigenetics. Immunity 24, 369-379 (2006).
115. H17 differentiation. J. Exp. Med. 204, 2825-2835 (2007).
116. Young, D. A. et al. Blockade of the interleukin-21/interleukin-21 receptor pathway ameliorates disease in animal models of rheumatoid arthritis. Arthritis Rheum. 56, 1152-1163 (2007).
117. Spolski, R. & Leonard, W. J. Interleukin-21: basic biology and implications for cancer and autoimmunity. Annu. Rev. Immunol. 26, 57-79 (2008).
118. Herber, D. et al. IL-21 has a pathogenic role in a lupus-prone mouse model and its blockade with IL-21R.Fc reduces disease progression. J. Immunol. 178, 3822-3830 (2007).